Organoids have been successfully exploited for drug screening, disease modeling, pathogenesis, and regenerative medicine. Herein, we discuss the progress achieved in the commercialization of organoids in the last few years. We further elaborate on the concept of organoid biobank and highlight ethical and regulatory issues surrounding organoid research and commercialization.

中文翻译：

---

类器官的商业化。

类器官已经成功地用于药物筛选，疾病建模，发病机理和再生医学。在此，我们讨论了最近几年在类器官商业化方面取得的进展。我们将进一步详细介绍类器官生物库的概念，并重点介绍有关类器官研究和商业化的伦理和监管问题。